Woodline Partners LP 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 09:05 am Sale | 2026-03-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 239,362 4.400% | -49,807 (-17.22%) | Filing |
| 2026-02-17 3:22 pm Sale | 2025-12-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 289,169 5.400% | -179,030 (-38.24%) | Filing |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 468,199 8.700% | -50,101 (-9.67%) | Filing |
| 2025-08-14 11:54 am Purchase | 2025-06-30 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 518,300 9.800% | 202,917 (+64.34%) | Filing |
| 2025-05-15 09:33 am Purchase | 2025-03-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Woodline Partners LP | 315,383 5.200% | 315,383 (New Position) | Filing |